Atlas Trials

Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma

Clinical trial NCT00484601 · TERMINATED

Trial details

NCT number
NCT00484601
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Refractory Nasopharyngeal Carcinoma
Start date
2004-04-15
Primary completion
2007-11-07
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.